LeMaitre Vascular, Inc. (Nasdaq: LMAT)

LeMaitre Vascular, Inc. (Nasdaq: LMAT) designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. 

Lately, the company has been on a roll—it has generated robust financial results and metrics that produced a high GF Score. But the share price has been in a slump.

The worldwide market for peripheral vascular devices stands at more than $5 billion, and the company’s addressable market is $750 million. In 2021, it generated $154.4 million, meaning it has the potential to grow 5 times over in its current configuration.

Expect changes in the configuration, though. The company is active in the acquisition game, with 24 transactions in the past 25 years.

Based in Burlington, Massachusetts, the company has a market cap of $1.1 billion.